The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT). (Q45279247)
Jump to navigation
Jump to search
scientific article published in December 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT). |
scientific article published in December 2004 |
Statements
1 reference
The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT). (English)
1 reference
Mohan Suntharalingam
1 reference
Jerry Jaboin
1 reference
Rodney Taylor
1 reference
Jeffrey Wolf
1 reference
Madan Banglore
1 reference
David Van Echo
1 reference
Robert Ord
1 reference
1 December 2004
1 reference
1 reference
6 Suppl 18
1 reference
Identifiers
1 reference